About last months #November & #December 2023



This is the key word of this month of November where we had the pleasure of welcoming Jean-François BREPSON during the 4th 𝐄𝐦𝐛𝐮̂𝐜𝐡𝐞𝐬 𝐝𝐞 𝐥’𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 : series of testimonies followed by an open and taboo-free exchange.

#CEO PathoQuest, a key player in the French bioproduction sector of innovative medicines but also historical relationship LallianSe since its creation 8 years ago, the developments of PathoQuest under the impetus and leadership of Jean-François offer a fine example of agile and efficient growth… even if it has not been an easy journey.

Cultivating #resilience, learning to turn failures into opportunities and using this shared experience to adjust your approach to the future is essential.

Then share a concrete and inspiring example based on values and our common ethics in a new episode of Do You Speak LallianSe ?

For more than 70 years, the Fondation pour la Recherche Médicale has been the essential private player in financing biomedical research in France. Since 2013, through the management of the Béatrice Denys Foundation under the aegis of the #FRM, the relationship with Julie has been created. And, since 2019 #LallianSe has been supporting the #FRM to initiate, explore and develop its inspiring and original approach to become a relevant player in the promotion and maturation of research projects.

Beyond the #sparringpartner and #operatingpartner approach, Julie & Emmanuelle have built a relationship of trust and quality by concretizing strategic issues, supporting operational implementation, by carrying out targeted interactions with stakeholders. keys while supporting internal teams on a daily basis.

Thanks to Valerie Lemarchandel Florence Guibal and all the FRM teams for their trust.

Finally, sharing expertise and defining common objectives are the keys to health innovation.

This is why we actively participated in the CHU Healthtech Connexion Day, organized by France Biotech in Marseille. During a workshop, Julie shared the fruits of our numerous #initiatives resulting from our hospital immersion, thus answering essential questions: how to define innovation – medical and paramedical – in hospitals? What are the conditions for the emergence of innovation in hospitals?

To innovate and develop effective health solutions, we must understand and absorb the needs of the market, staff, users and especially patients. We have been present in the field, for the last 8 years, to outline trajectories through our innovation competitions (#ChallengeInnovation / #ParInnovChallenge), more recently, the creation of #ASIIA or our flagship initiatives like BrainTale.

Our commitment doesn’t stop there! And speaking of BrainTale, Julie inaugurated GROUPE MACSF brand new podcast project by answering a more general question: how to improve the health of tomorrow?

Julie was able to present a future in which, thanks to a better knowledge of the brain, BrainTale, will allow us to anticipate, prevent and adjust our care pathways and our preventive vision to improve our brain health. 🎧 To listen to it, go here.



At #LallianSe, we believe in the power of #synergies, #network and shared #values.

A recent Doctor of Pharmacy graduate, Eilone has led important work on the question of how #CDMOs drive innovation within the biologics industry. With her in-depth understanding of the CDMO market and landscape, as well as her experience in #capitaldev, Eilone joined our #Expert #network a few months ago as a junior project manager. At (only) 27 years old, his added value and vision brought dynamic energy and strengthened our commitment to the younger generation. Meet Eilone in our latest 𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞 ?

Being an integrator means helping to open up perspectives to build an environment favorable to the success of health innovations – and this requires the integration of the international vision…

This year again LallianSe will be present in San Francisco for #JPMorgan week and will partner with #BusinessFrance for #FrenchHealthcareAfterwork next Monday January 8.

Are you nearby? Join us !

A big thank you to the entire #team Business France Healthcare – North America Jerome Revole Marie-Astrid Sevilla Ludmilla Potiron Camille Risso and our partners for the week and the event ORCOM US ICOSA Voisin Consulting Life Sciences (VCLS) CCI GRAND EST France Biotech Eurobiomed

…or even by the European vision….

For the 3rd consecutive year we are a partner of BioFIT Event, a European event dedicated to technology transfer, collaborations between industrialists and academics and early-stage innovations.

#BioFIT is also a European marketplace for seed #investment and venture capital. As a #Health Integrator, #LallianSe supports the actions around this event: an #opportunity to explore future #collaborations with the ecosystem.

And finally how to evaluate the potential of your innovation and how to create a solid value proposition of your startup?

Remember, we started the summer of 2023 by inaugurating the 1st edition of the “Startup Alumni Breakfasts” of the Institut Pasteur. Invited by Alexandre Batch during the 2nd session of the “Startup Breakfast” Julie had the opportunity to answer these questions in an interactive format.

Crucial steps for the success of #startups, since 2015 LallianSe has made it its mission: to build the environment favorable to the economic success of health innovations by articulating investment theses, through tailor-made courses and an approach agile.

We were happy to contribute to these questions. We are also preparing a surprise for you with the Institut Pasteur… stay tuned!

Finally… to everyone – clients, experts and entrepreneurs in residence, coworkers, partners, entrepreneurs, investors, hospital staff and all those who follow our adventures:

The year #2023 is ending, it’s time to wish you all a very happy holiday. But also to say M E R C I! #Thank you for these #synergies, these exchanges, and these projects, which are always more inspiring, attractive and motivating. Thanks to you, a virtuous circle is being built, and this is the greatest reward for us. 

See you in 2024 🚀